Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia

Inge van der Sluis; Anja Moericke; Gabriele Escherich; Arend von Stackelberg; Wolfgang Holter; Thomas Klingebiel; Christian Flotho; Sabine Legien; Wim Tissing; Marc Bierings; Cecile Guimbal-Schmolck; Uwe Pichlmeier; Hans-Juergen Kuehnel; Rob Pieters

doi:10.3324/haematol.2013.090563

Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia

Inge van der Sluis^*, Anja Moericke, Gabriele Escherich, Arend von Stackelberg, Wolfgang Holter, Thomas Klingebiel, Christian Flotho, Sabine Legien, Wim Tissing, Marc Bierings, Cecile Guimbal-Schmolck, Uwe Pichlmeier, Hans-Juergen Kuehnel, Rob Pieters

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

435 Downloads (Pure)

Abstract

The pharmacokinetics, pharmacodynamics, efficacy and safety of a new recombinant E. coli-asparaginase preparation were evaluated in infants (

Original language	English
Pages (from-to)	1697-1701
Number of pages	5
Journal	Haematologica
Volume	98
Issue number	11
DOIs	https://doi.org/10.3324/haematol.2013.090563
Publication status	Published - Nov-2013

Keywords

TRIAL

Access to Document

10.3324/haematol.2013.090563Licence: Unspecified

Pediatric Acute Lymphoblastic Leukemia: Efficacy And Safety Of Recombinant E. Coli-Asparaginase In InfantsFinal publisher's version, 184 KBLicence: Unspecified

Handle.net

Persistent link

Cite this

van der Sluis, I., Moericke, A., Escherich, G., von Stackelberg, A., Holter, W., Klingebiel, T., Flotho, C., Legien, S., Tissing, W., Bierings, M., Guimbal-Schmolck, C., Pichlmeier, U., Kuehnel, H.-J., & Pieters, R. (2013). Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia. Haematologica, 98(11), 1697-1701. https://doi.org/10.3324/haematol.2013.090563

@article{977dd5ac38f4483ebcc636dec686a2de,

title = "Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia",

abstract = "The pharmacokinetics, pharmacodynamics, efficacy and safety of a new recombinant E. coli-asparaginase preparation were evaluated in infants (",

keywords = "TRIAL",

author = "{van der Sluis}, Inge and Anja Moericke and Gabriele Escherich and {von Stackelberg}, Arend and Wolfgang Holter and Thomas Klingebiel and Christian Flotho and Sabine Legien and Wim Tissing and Marc Bierings and Cecile Guimbal-Schmolck and Uwe Pichlmeier and Hans-Juergen Kuehnel and Rob Pieters",

year = "2013",

month = nov,

doi = "10.3324/haematol.2013.090563",

language = "English",

volume = "98",

pages = "1697--1701",

journal = "Haematologica",

issn = "0390-6078",

publisher = "FERRATA STORTI FOUNDATION",

number = "11",

}

van der Sluis, I, Moericke, A, Escherich, G, von Stackelberg, A, Holter, W, Klingebiel, T, Flotho, C, Legien, S, Tissing, W, Bierings, M, Guimbal-Schmolck, C, Pichlmeier, U, Kuehnel, H-J & Pieters, R 2013, 'Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia', Haematologica, vol. 98, no. 11, pp. 1697-1701. https://doi.org/10.3324/haematol.2013.090563

Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia. / van der Sluis, Inge; Moericke, Anja; Escherich, Gabriele et al.
In: Haematologica, Vol. 98, No. 11, 11.2013, p. 1697-1701.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia

AU - van der Sluis, Inge

AU - Moericke, Anja

AU - Escherich, Gabriele

AU - von Stackelberg, Arend

AU - Holter, Wolfgang

AU - Klingebiel, Thomas

AU - Flotho, Christian

AU - Legien, Sabine

AU - Tissing, Wim

AU - Bierings, Marc

AU - Guimbal-Schmolck, Cecile

AU - Pichlmeier, Uwe

AU - Kuehnel, Hans-Juergen

AU - Pieters, Rob

PY - 2013/11

Y1 - 2013/11

N2 - The pharmacokinetics, pharmacodynamics, efficacy and safety of a new recombinant E. coli-asparaginase preparation were evaluated in infants (

AB - The pharmacokinetics, pharmacodynamics, efficacy and safety of a new recombinant E. coli-asparaginase preparation were evaluated in infants (

KW - TRIAL

U2 - 10.3324/haematol.2013.090563

DO - 10.3324/haematol.2013.090563

M3 - Article

SN - 0390-6078

VL - 98

SP - 1697

EP - 1701

JO - Haematologica

JF - Haematologica

IS - 11

ER -

Pediatric Acute Lymphoblastic Leukemia Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this